Klaria Pharma Holding AB (publ.) KLAR
Updated: 8 Sep 2026
No signal published yet
We already track Klaria Pharma Holding and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Klaria Pharma Holding AB (publ.)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Klaria Pharma Holding free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On September 1, 2026, Klaria announced an extraordinary general meeting scheduled for October 5, 2026, to vote on a rights issue of units aiming to raise up to approximately SEK 148 million before issue costs. The proceeds are intended to strengthen the company's financial position and fund the continued commercialization and development of its migraine candidate Sumatriptan Alginate Film.
What Firelda Watch includes for Klaria Pharma Holding AB (publ.)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Klaria Pharma Holding AB (publ.)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Klaria Pharma Holding free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more